Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773)

Clinical trial NCT00656799 · COMPLETED

Trial details

NCT number: NCT00656799
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuromuscular Blockade

Start date: 2008-04-01
Primary completion: 2009-07-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.